SCHEMBL9116950

SCHEMBL9116950

CN(C)CCC1(c2ccc(-c3ccccc3)cc2)CCC1

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 9/20 0.53
SLC6A2 P23975 8/20 0.53
SLC6A3 Q01959 8/20 0.53
EPHX2 P34913 1/20 0.43
LSS P48449 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRL1 P41146 1/20 0.41
DPP4 P27487 1/20 0.40
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
DRD2 P14416 1/20 0.39
SIGMAR1 Q99720 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5311542 0.88 SLC6A4 (0.51) SLC6A4SLC6A2SLC6A3LSSTAAR1
SCHEMBL8354603 0.81 SLC6A4 (0.44) SLC6A4SLC6A2SLC6A3EPHX2OPRM1
SCHEMBL5646483 0.80 SLC6A4 (0.42) SLC6A4SLC6A2SLC6A3EPHX2
SCHEMBL11111686 0.80 SLC6A4 (0.42) SLC6A4SLC6A2SLC6A3EPHX2
Hydrochloric Acid SCHEMBL11105518 0.79 SLC6A4 (0.61) SLC6A4SLC6A2SLC6A3EPHX2
Hydrochloric Acid SCHEMBL6477899 0.79 SLC6A4 (0.41) SLC6A4SLC6A2SLC6A3EPHX2
SCHEMBL9116606 0.79 SLC6A4 (0.42) SLC6A4SLC6A2SLC6A3EPHX2LSS
SCHEMBL14347875 0.78 SLC6A4 (0.47) SLC6A4SLC6A2SLC6A3EPHX2
SCHEMBL5645141 0.77 SLC6A3 (0.46) SLC6A4SLC6A2SLC6A3DPP4
SCHEMBL11634132 0.74 SLC6A4 (0.48) SLC6A4SLC6A2SLC6A3OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995021615-A1 USE OF ARYLCYCLOBUTYLALKYLAMINES FOR THE TREATMENT OF SEIZURES AND NEUROLOGICAL DISORDERS KNOLL AG (DE) 1995-08-17 WO claimed
WO-1995021615-A1 USE OF ARYLCYCLOBUTYLALKYLAMINES FOR THE TREATMENT OF SEIZURES AND NEUROLOGICAL DISORDERS KNOLL AG (DE) 1995-08-17 WO disclosed